Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
- PMID: 34437808
- PMCID: PMC8424689
- DOI: 10.1021/acsinfecdis.1c00237
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
Abstract
The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical inhibition. Mpro is conserved among coronaviruses and distinct from human proteases. Viral replication depends on the cleavage of the viral polyprotein at multiple sites. We present crystal structures of SARS-CoV-2 Mpro bound to two viral substrate peptides. The structures show how Mpro recognizes distinct substrates and how subtle changes in substrate accommodation can drive large changes in catalytic efficiency. One peptide, constituting the junction between viral nonstructural proteins 8 and 9 (nsp8/9), has P1' and P2' residues that are unique among the SARS-CoV-2 Mpro cleavage sites but conserved among homologous junctions in coronaviruses. Mpro cleaves nsp8/9 inefficiently, and amino acid substitutions at P1' or P2' can enhance catalysis. Visualization of Mpro with intact substrates provides new templates for antiviral drug design and suggests that the coronavirus lifecycle selects for finely tuned substrate-dependent catalytic parameters.
Keywords: Mpro; SARS-CoV-2; protease; virology.
Conflict of interest statement
Mark Namchuk is the recipient of funding from AbbVie. The funding did not contribute to this work.
Figures
Similar articles
-
Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CLpro main protease (Mpro) from proteomic identification of P6-P6' active site specificity.J Virol. 2024 Jun 13;98(6):e0004924. doi: 10.1128/jvi.00049-24. Epub 2024 May 14. J Virol. 2024. PMID: 38742901 Free PMC article.
-
Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 main protease using a linked protein FRET platform.J Biol Chem. 2024 Jun;300(6):107367. doi: 10.1016/j.jbc.2024.107367. Epub 2024 May 15. J Biol Chem. 2024. PMID: 38750796 Free PMC article.
-
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.ACS Comb Sci. 2020 Jun 8;22(6):297-305. doi: 10.1021/acscombsci.0c00058. Epub 2020 May 27. ACS Comb Sci. 2020. PMID: 32402186 Review.
-
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.Antiviral Res. 2011 Nov;92(2):204-12. doi: 10.1016/j.antiviral.2011.08.001. Epub 2011 Aug 11. Antiviral Res. 2011. PMID: 21854807 Free PMC article.
-
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors.Curr Top Med Chem. 2021;21(6):442-460. doi: 10.2174/1568026620666201207095117. Curr Top Med Chem. 2021. PMID: 33292134 Review.
Cited by
-
Unsupervised deep learning for molecular dynamics simulations: a novel analysis of protein-ligand interactions in SARS-CoV-2 Mpro.RSC Adv. 2023 Nov 22;13(48):34249-34261. doi: 10.1039/d3ra06375e. eCollection 2023 Nov 16. RSC Adv. 2023. PMID: 38019981 Free PMC article.
-
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds.Comput Struct Biotechnol J. 2022;20:1306-1344. doi: 10.1016/j.csbj.2022.03.009. Epub 2022 Mar 14. Comput Struct Biotechnol J. 2022. PMID: 35308802 Free PMC article. Review.
-
Coronaviral Main Protease Induces LPCAT3 Cleavage and Endoplasmic Reticulum (ER) Stress.Viruses. 2023 Aug 5;15(8):1696. doi: 10.3390/v15081696. Viruses. 2023. PMID: 37632038 Free PMC article.
-
The Inhibitory Potential of Ferulic Acid Derivatives against the SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and ADMET Evaluation.Biomedicines. 2022 Jul 25;10(8):1787. doi: 10.3390/biomedicines10081787. Biomedicines. 2022. PMID: 35892687 Free PMC article.
-
Allostery in homodimeric SARS-CoV-2 main protease.Commun Biol. 2024 Nov 4;7(1):1435. doi: 10.1038/s42003-024-07138-w. Commun Biol. 2024. PMID: 39496839 Free PMC article.
References
-
- Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R, Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003, 300, 1763–1767. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
